retatrutide triple agonist glp-1 gip glucagon phase 2 results Retatrutide: How the Compares to Tirzepatide Lilly's triple agonist delivers up

J Clin Epidemiol 2000

This is the core logic behind glutathione supplements for dogs: not to override biology, but to support it when the balance feels strained

Studies examining body composition changes during GLP-1 therapy, including the STEP trials (semaglutide) and SURMOUNT-1 (tirzepatide), have demonstrated that approximately 2540% of total weight lost may come from lean body mass, including skeletal muscle, rather than exclusively from fat mass

Results showed: Significant increase in skin density and thickness Measurable reduction in fine line depth (up to 35% in some cohorts) Improved skin laxity and elasticity scores Enhanced skin moisture retention These effects are largely attributed to GHK-Cus ability to stimulate fibroblast activity the cells responsible for producing collagen type I and III, elastin, and hyaluronic acid